Fatal Immune Checkpoint Inhibitor-related Pancreatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fatal Immune Checkpoint Inhibitor-related Pancreatitis

Published:2021-12-15 Issue:24 Volume:60 Page:3905-3911
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ueno Masayuki¹,Tsuji Yoshihisa²,Yokoyama Toshihide³,Koyama Takashi⁴,Uenishi Yosuke¹,Ishida Etsuji¹,Mizuno Motowo¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Japan

2. Department of Community and General Medicine, Sapporo Medical University, Japan

3. Department of Respiratory Medicine, Kurashiki Central Hospital, Japan

4. Department of Diagnostic Radiology, Kurashiki Central Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/24/60_7366-21/_pdf

Reference26 articles.

1. 1. Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells. Immunol Cell Biol 96: 21-33, 2018.

2. 2. Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol 2: 1346-1353, 2016.

3. 3. Pelaez-Luna M, Soriano-Rios A, Lira-Treviño AC, Uscanga-Domínguez L. Steroid-responsive pancreatitides. World J Clin Cases 8: 3411-3430, 2020.

4. 4. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67: 46-51, 2014.

5. 5. Takeda K, Yokoe M, Takada T, et al. Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. J Hepatobiliary Pancreat Sci 17: 37-44, 2010.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis;Investigational New Drugs;2024-06-03

2. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors;Alimentary Pharmacology & Therapeutics;2024-04-08

3. Knowledge domains and emerging trends in immune-related adverse events from immune checkpoint inhibitors: A bibliometrics and visualized analysis;Heliyon;2024-03

4. Case Report: Hypertriglyceridemia-Induced Pancreatitis after Lenvatinib and Pembrolizumab Use;Case Reports in Oncology;2024-02-22

5. Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2023-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3